Dr Eckman has received a number of grants, including university grants for Using Decision Analytic Modeling to Guide the ACCP Guideline Development Process for Antithrombotic Therapy in Atrial Fibrilla- tion (Foundation for Informed Medical Decision Making; $185,000) and has the following industry grants: Cost-Effectiveness of Screening for Chronic Hepatitis C Infection (Merck/Schering- Plough; September 2012; $58,000) and Cost-Effectiveness of Screening for Chronic Hepatitis B Infection (Gilead Sciences Inc; $56,000). He served as a consultant for Savient Pharmaceuticals ($300). Dr Hylek has participated in a symposium sponsored by Boehringer Ingelheim, served on advisory boards (Bayer Healthcare Pharmaceuticals; Boehringer Ingelheim GmbH; Bristol-Myers Squibb; Daiichi-Sankyo, Inc; Johnson & Johnson; Merck and Co, Inc; Ortho-McNeil Pharmaceutical, Inc; and P zer Inc) for amounts totaling ,$10,000 and participated at the steering committee level for several pharmaceutical-sponsored studies (ARISTOTLE trial sponsored by Bristol-Myers Squibb and P zer Inc [, $10,000] and ORBIT-AF Registry sponsored by Ortho-McNeil Pharma- ceutical, Inc [,$10,000]). Dr Go has received research funding from the National Heart, Lung, and Blood Institute related to anti- thrombotic therapy in atrial brillation and was a site principal investigator for a clinical trial sponsored by Johnson & Johnson and Bayer Healthcare Pharmaceuticals. Dr Halperin has received consulting fees from the following pharmaceutical manufacturers for advisory activities involving the development of anticoagulant drugs, none of which are currently approved for clinical use in any indication in the United States: Astellas Pharma, US; Bayer AG HealthCare; Boehringer Ingelheim; Daiichi Sankyo; Johnson & Johnson; and Sano -Aventis. He has received honoraria from Portola Pharmaceuticals, Inc as a member of the Data Safety Monitoring Board of its Phase II EXPLORE-AF trial involving an investi- gational anticoagulant for prevention of thromboembolism in patients with atrial brillation. 